Homocysteine and Alzheimer's disease: a modifiable risk?

Barney E. Dwyer; Arun K. Raina; George Perry; Mark A. Smith

doi:10.1016/j.freeradbiomed.2004.03.009

Related publications

Article2023

Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease

Christy Taylor, Dongyu Wang, Martin G. Larson, Emily S. Lau, Emelia Benjamin, Ralph B. D’Agostino, Ramachandran S. Vasan, Daniel Levy, Susan Cheng, Jennifer E. Ho

Article2001

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease

Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid, Marcia Landa, Guiseppe Maschio, Carmelita Marcantoni, Paul E. de Jong, Dick de Zeeuw, Shahnaz Shahinfar, Piero Ruggenenti, Giuseppe Remuzzi, Andrew S. Levey, for the Aiprd Study Group

Letter2003

Estrogen Replacement and Risk of Alzheimer Disease

Mark A. Smith, George Perry, Craig Atwood, Richard L. Bowen

Editorial Material2025

Is US residence a risk factor for Alzheimer's disease?

Poul Flemming Høilund‐Carlsen, Abass Alavi, Tommaso Costa, Rachael L. Neve, George Perry, Mona‐Elisabeth Revheim, Jorge R. Barrio

Article2007

Inflammatory markers and the risk of Alzheimer disease

Zaldy S. Tan, Alexa S. Beiser, Ramachandran S. Vasan, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia Benjamin, Rhoda Au, Douglas P. Kiel, P. A. Wolf, Sudha Seshadri